Skip to main content
. 2017 May 21;2017:6121760. doi: 10.1155/2017/6121760

Table 3.

Parameters selected for analysis.

Parameter Selected for analyses
Period of reported results (minimum follow-up period) (i) BOLT: 18-month update (18 months of follow-up) 
(ii) ERIVANCE: 12-month update (21 months of follow-up)

Efficacy outcomes (i) ORR 
(ii) DOR 
(iii) PFS

Matching variables (i) Prior BCC radiotherapy 
(ii) Prior BCC surgery

BCC: basal cell carcinoma; DOR: duration of response; ORR: objective response rate; PFS: progression-free survival.